Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Profit After Tax: 2020-2025

Historic Profit After Tax for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$14,796.

  • Molecular Partners Ag's Profit After Tax rose 21.85% to -$14,796 in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.3 million, marking a year-over-year decrease of 47.61%. This contributed to the annual value of -$61.4 million for FY2024, which is 10.99% up from last year.
  • Per Molecular Partners Ag's latest filing, its Profit After Tax stood at -$14,796 for Q3 2025, which was up 99.94% from -$24.6 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Profit After Tax ranged from a high of $168.7 million in Q4 2021 and a low of -$61.6 million during Q4 2024.
  • Its 3-year average for Profit After Tax is -$14.8 million, with a median of -$18,934 in 2024.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 1,005.57% in 2022, then plummeted by 378,595.28% in 2023.
  • Over the past 5 years, Molecular Partners Ag's Profit After Tax (Quarterly) stood at $168.7 million in 2021, then declined by 27.55% to $122.2 million in 2022, then plummeted by 134.18% to -$41.8 million in 2023, then crashed by 47.59% to -$61.6 million in 2024, then grew by 21.85% to -$14,796 in 2025.
  • Its Profit After Tax was -$14,796 in Q3 2025, compared to -$24.6 million in Q2 2025 and -$18,654 in Q1 2025.